Complex Regional Pain Syndromes: Clinical Trials

22 trials for Complex Regional Pain Syndromes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 5 terminated, 4 unknown, 3 withdrawn. 22 Phase 2, 5 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 222Completed 9, Terminated 5, Unknown 4, Withdrawn 3, Suspended 1
Phase 35Completed 3, Unknown 1, Withdrawn 1
Phase 12Completed 1, Withdrawn 1

Follow Complex Regional Pain Syndromes: new trials by email Literature Review of Complex Regional Pain Syndromes trials Research Report on Complex Regional Pain Syndromes

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine and Midazolam Infusions for CRPS: Feasibility Study
Ketamine, Midazolam, Normal Saline - Complex Regional Pain Syndromes
Phase 2WithdrawnStanford University2099-01-012024-11-22
Ketamine HCl Prolonged Release Oral Tablets for CRPS
80mg/day Ketamine HCl Prolonged Release, 160mg/day Ketamine HCl Prolonged Release - Complex Regional Pain Syndromes
Phase 2SuspendedUniversity of Southern California652027-01-012026-07-27
Peripheral Nerve Injections for CRPS
Triamcinolone Acetonide 40mg/mL, Saline Injection, Bupivacaine - Complex Regional Pain Syndromes
Phase 2UnknownOttawa Hospital Research Institute502024-05-302024-09-19
Effectiveness of Ketamine Administered by Mesotherapy in Complex Regional Pain Syndrome Type 1 (CRPS1)
LIDOCAINE 20 mg, LIDOCAINE 20 mg + KETAMINE 20 mg, LIDOCAINE 20 mg + KETAMINE 40 mg - Neuropathic Pain, Complex Regional Pain Syndrome Type 1
Phase 2 / Phase 3CompletedHospices Civils de Lyon312021-11-052026-08-10
Study of TAK-935 as an Adjunctive Therapy in Adult Participants With Complex Regional Pain Syndrome (CRPS)
Soticlestat, Placebo - Complex Regional Pain Syndrome
Phase 2CompletedMillennium Pharmaceuticals, Inc.242019-07-232026-09-14
Adipose Stem/Stromal Cells in RSD, CRPS, Fibromyalgia
Lipoaspiration, ADcSVF isolation, Normal Saline IV - RSD (Reflex Sympathetic Dystrophy), CRPS - Complex Regional Pain Syndrome Type I
Phase 1 / Phase 2WithdrawnHealeon Medical Inc2018-12-152021-02-16
Novel Treatment Option for Neuropathic Pain
Cetuximab, Placebo - Neuralgia, Complex Regional Pain Syndromes
Phase 2CompletedSorlandet Hospital HF152015-10-012016-11-08
Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I
Placebo, Neridronic acid 62.5 mg - Complex Regional Pain Syndrome, Type I
Phase 2 / Phase 3CompletedGrĂ¼nenthal GmbH4592015-04-012018-05-09
Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome
Ketamine Infusion + Epidural Infusion, Control Group + Epidural infusion, Ketamine Booster Infusion - Complex Regional Pain Syndrome
Phase 2TerminatedHospital for Special Surgery, New York32014-03-242018-01-31
The Use of Zoledronic Acid to Complex Regional Pain Syndrome
Zoledronic acid, Placebo - Complex Regional Pain Syndromes
Phase 2UnknownUniversity of Sao Paulo General Hospital402013-12-012013-02-11
Acupuncture for Post-stroke Shoulder-hand Syndrome
rehabilitation, Acupuncture - Shoulder-hand Syndrome
Phase 2 / Phase 3UnknownZouqin Huang902013-10-012013-12-13
Efficacy of Etoricoxib on Peripheral Hyperalgesia
Etoricoxib, placebo - Causalgia, Polyneuropathy
Phase 2TerminatedRuhr University of Bochum92011-02-012012-08-24
Effects of Vaporized Marijuana on Neuropathic Pain
Mild dose cannabis, Low dose cannabis, Cannabis - Neuropathic Pain, Reflex Sympathetic Dystrophy
Phase 1 / Phase 2CompletedUniversity of California, Davis442009-12-012018-01-31
Pain Exposure Physical Therapy (PEPT) Versus CBO in Patients With Complex Regional Pain Syndrome Type I (CRPS-1)
PEPT, CBO standard - Complex Regional Pain Syndrome, Type I
Phase 2 / Phase 3CompletedRadboud University Medical Center622009-01-012013-07-24
Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)
Placebo, Ethosuximide - Complex Regional Pain Syndromes
Phase 2TerminatedMcGill University Health Centre/Research Institute of the McGill University Health Centre42008-09-012011-05-13
Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS
Ketamine, IV NSS, Normal Saline - Complex Regional Pain Syndrome
Phase 2CompletedDrexel University College of Medicine402006-09-012010-06-17
Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study)
Delta9-Tetrahydrocannabinol - Complex Regional Pain Syndromes, CRPS
Phase 2UnknownLudwig-Maximilians - University of Munich1002006-09-012008-06-30
Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception
laboratory pain assessment, transcranial magnetic stimulation - Pain, Trigeminal Neuralgia
Phase 2 / Phase 3WithdrawnMedical University of South Carolina2006-07-012012-04-30
Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1
lenalidomide, Placebo - Complex Regional Pain Syndrome, Type I
Phase 2TerminatedCelgene Corporation1842005-02-012013-08-28
Clonidine Versus Adenosine to Treat Neuropathic Pain
clonidine, adenosine, placebo - Pain
Phase 2CompletedWake Forest University Health Sciences242004-08-012018-09-10

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Reflex Sympathetic Dystrophy (9)  ·  Neuralgia (7)  ·  Pain (5)  ·  Chronic Pain (4)  ·  Agnosia (2)  ·  Causalgia (2)  ·  Neuralgia, Postherpetic (2)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Fibromyalgia (1)  ·  Marijuana Abuse (1)  ·  Multiple Sclerosis (1)  ·  Peripheral Nerve Injuries (1)  ·  Peripheral Nervous System Diseases (1)  ·  Polyneuropathies (1)

Broader conditions

Autonomic Nervous System Diseases (22)  ·  Nervous System Diseases (22)  ·  Neuromuscular Diseases (22)  ·  Peripheral Nervous System Diseases (21)  ·  Neurologic Manifestations (13)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Signs and Symptoms (13)  ·  Pain (7)  ·  Immune System Diseases (2)  ·  Mental Disorders (2)  ·  Neurobehavioral Manifestations (2)  ·  Perceptual Disorders (2)  ·  Trauma, Nervous System (2)  ·  Wounds and Injuries (2)

Interventions

Ketamine (4)  ·  Sodium Chloride (3)  ·  Lenalidomide (2)  ·  Saline Solution (2)  ·  1,10-phenanthroline-platinum(II)-ethylenediamine (1)  ·  6-amino-1-hydroxyhexane-1,1-diphosphonate (1)  ·  Acupuncture Therapy (1)  ·  Adenosine (1)  ·  Bupivacaine (1)  ·  Cetuximab (1)  ·  Clonidine (1)  ·  Control Groups (1)  ·  Dronabinol (1)  ·  Ethosuximide (1)  ·  Etoricoxib (1)

Sponsors

Celgene Corporation (2)  ·  Drexel University College of Medicine (1)  ·  GrĂ¼nenthal GmbH (1)  ·  Healeon Medical Inc (1)  ·  Hospices Civils de Lyon (1)  ·  Hospital for Special Surgery, New York (1)  ·  Ludwig-Maximilians - University of Munich (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Medical University of South Carolina (1)  ·  Millennium Pharmaceuticals, Inc. (1)  ·  National Institute of Nursing Research (NINR) (1)  ·  Ottawa Hospital Research Institute (1)  ·  Radboud University Medical Center (1)  ·  Ruhr University of Bochum (1)  ·  Sorlandet Hospital HF (1)

Countries

United States (12)  ·  Germany (3)  ·  Canada (2)  ·  United Kingdom (2)  ·  Brazil (1)  ·  China (1)  ·  France (1)  ·  Honduras (1)  ·  Netherlands (1)  ·  Norway (1)

Top investigators

Barth L Wilsey, MD (1)  ·  Christian Kersten, MD PhD (1)  ·  Christoph Maier, Dr.med (1)  ·  Daniel I Richman, MD (1)  ·  Donald C Manning, MD, PhD (1)  ·  Donald Manning, MD, PhD (1)  ·  Glenn C Terry, MD (1)  ·  Huang Zouqin, Dcctor (1)  ·  James C. Eisenach, M.D. (1)  ·  Jeffrey J. Borckardt, Ph.D. (1)  ·  Leorey Saligan, PhD, CRNP (1)  ·  Linamara R. Battistella, PHD (1)  ·  Mark A Ware, MD (1)

Results publications

PMID 22515496, PMID 25283471, PMID 25919011, PMID 26628523, PMID 31106835, PMID 36538782, PMID 42421175

NIH funding

2009 (1), 2014 (1), 2015 (1), K23NS050485 (1), P01NS041386 (1)